1. Age differences in the sensitivity to clomipramine in an animal model of obsessive-compulsive disorder

   • A. Fernández-Guasti
   • R. E. Ulloa
   • H. Nicolini

   Original Investigation 13 February 2003 Pages: 195 - 201

   

2. Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice

   • William E. Fantegrossi
   • Tomek Godlewski
   • James H. Woods

   Original Investigation Pages: 202 - 211

3. Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus)

   • N. G. Muggleton
   • A. P. Bowditch
   • P. C. Pearce

   Original Investigation 13 February 2003 Pages: 212 - 220

   

4. Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers

   • Ashwin A. Patkar
   • Raman Gopalakrishnan
   • Frank T. Leone

   Original Investigation 13 February 2003 Pages: 221 - 227

   

5. Cognitive and motor function after administration of hydrocodone bitartrate plus ibuprofen, ibuprofen alone, or placebo in healthy subjects with exercise-induced muscle damage: a randomized, repeated-dose, placebo-controlled study

   • George J. Allen
   • Tamara L. Hartl
   • Carl M. Maresh

   Original Investigation 28 January 2003 Pages: 228 - 233

   

6. Occupancy of 5-HT_1A receptors by clozapine in the primate brain: a PET study

   • Yuan-Hwa Chou
   • Christer Halldin
   • Lars Farde

   Original Investigation Pages: 234 - 240

7. Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice

   • Yossef Itzhak
   • Syed F. Ali
   • Karen L. Anderson

   Original Investigation 18 February 2003 Pages: 241 - 248

   

8. The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats

   • B. J. Gehrke
   • S. B. Harrod
   • M. T. Bardo

   Original Investigation 13 February 2003 Pages: 249 - 257

   

9. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-d-aspartate receptor antagonist MK-801 in mice

   • Oscar P. Dall'Igna
   • Adriana L. da Silva
   • Diogo R. Lara

   Original Investigation 13 February 2003 Pages: 258 - 263

   

10. Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma

    • Nora D. Volkow
    • Gene-Jack Wang
    • James M. Swanson

    Original Investigation 13 February 2003 Pages: 264 - 270

    

11. Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine

    • Cornelius Schüle
    • Thomas Baghai
    • Rainer Rupprecht

    Original Investigation 28 January 2003 Pages: 271 - 275

    

12. Buspirone-induced antinociception is mediated by l-type calcium channels and calcium/caffeine-sensitive pools in mice

    • Jian-Hui Liang
    • Xu-Hua Wang
    • Ji-Wang Zheng

    Original Investigation 28 January 2003 Pages: 276 - 283

    

13. EEG effects of buspirone and pindolol: a method of examining 5-HT_1A receptor function in humans

    • R. H. McAllister-Williams
    • A. E. Massey

    Original Investigation 13 February 2003 Pages: 284 - 293

    

14. Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI)

    • Peter Eichhammer
    • Berthold Langguth
    • Göran Hajak

    Original Investigation 01 February 2003 Pages: 294 - 297

    

15. Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys

    • Donna M. Platt
    • Joshua S. Rodefer
    • Roger D. Spealman

    Original Investigation 13 February 2003 Pages: 298 - 305

    

16. The motivational valence of nicotine in the rat ventral tegmental area is switched from rewarding to aversive following blockade of the α7-subunit-containing nicotinic acetylcholine receptor

    • Steven R. Laviolette
    • Derek van der Kooy

    Original Investigation 05 February 2003 Pages: 306 - 313